Placeholder Banner

BIO Applauds Advancement of Senate Innovation Initiative Legislation

February 10, 2016

Washington, D.C. (February 10, 2016) – The Biotechnology Innovation Organization (BIO) applauds the passage yesterday by the Senate Health Committee of legislative components of the bipartisan Innovation Initiative to accelerate the pace of medical advancement.

“BIO is extremely encouraged by the broad bipartisan votes yesterday by the Senate Health Committee to advance components of the Senate Innovation Initiative,” said BIO President and CEO Jim Greenwood. “We applaud Chairman Alexander and Ranking Member Murray for working towards final passage of these bills to improve the US healthcare system and encourage increased investment in medical innovation. We hope that these bills and others being considered by the Committee as part of this initiative will continue to enjoy broad bipartisan support. We look forward to working with members of the Committee on common sense reforms that will improve the ecosystem of innovation which patients rely upon to deliver new treatments.”

Upcoming BIO Events 

BIO International Convention
June 6-9, 2016
San Francisco, Calif.

BIO-Europe Spring
April 4-6, 2016
Stockholm, Sweden

13th Annual BIO Asia International Conference
March 15-16, 2016
Tokyo, Japan

 


###

 

 

Discover More
Seed technology companies comply with Mexico’s biosafety regulations, and Mexico should do the same, BIO said today in its response to the panel set up to determine if Mexico’s ban on imports of genetically modified corn violate its commitments…
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry plays as a vital strategic asset: “As a…
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…